Web Results

Lomustine

en.wikipedia.org/wiki/Lomustine

Lomustine (INN), abbreviated CCNU is an alkylating nitrosourea compound used in chemotherapy. It is closely related to semustine and is in the same family as ...

Lomustine (CCNU): Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/lomustine-ccnu.html

Lomustine (CCNU) is usually taken as a single dose only once every 6 weeks. Do NOT take a dose of lomustine (CCNU) more than once within a 6-week period  ...

Lomustine: MedlinePlus Drug Information

medlineplus.gov/druginfo/meds/a682207.html

Mar 15, 2016 ... Lomustine can cause a severe decrease in the number of blood cells in your bone marrow. A decrease in the number of blood cells in your ...

Lomustine (CCNU) | Cancer Research UK

www.cancerresearchuk.org/about-cancer/cancers-in-general/treatment/cancer-drugs/lomustine

Apr 28, 2015 ... Read about the cancer treatment drug lomustine, otherwise known as CCNU, including what it is, how it works and possible side effects.

CeeNu (lomustine) - U.S. Food and Drug Administration

www.accessdata.fda.gov/drugsatfda_docs/label/2009/017588s034lbl.pdf

(lomustine). Capsules. WARNINGS. CeeNU (lomustine) should be administered under the supervision of a qualified physician experienced in the use of cancer ...

lomustine | C9H16ClN3O2 - PubChem

pubchem.ncbi.nlm.nih.gov/compound/lomustine

Lomustine is a nitrosourea with antineoplastic activity. Lomustine alkylates and crosslinks DNA, thereby inhibiting DNA and RNA synthesis. This agent also ...

lomustine oral : Uses, Side Effects, Interactions, Pictures, Warnings ...

www.webmd.com/drugs/2/drug-8801/lomustine-oral/details

Find patient medical information for lomustine oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Lomustine (Oral Route) Description and Brand Names - Mayo Clinic

www.mayoclinic.org/drugs-supplements/lomustine-oral-route/description/drg-20064559

Dec 1, 2015 ... Lomustine is used alone or in combination with other medicines to treat brain tumors, Hodgkin's disease, and other kinds of cancer.

Lomustine (CeeNU®, CCNU) | Oncolink - Cancer Resources

www.oncolink.org/treatment/article.cfm?c=143&id=137

Jan 6, 2016 ... Lomustine is an alkylating agent used in the treatment of brain tumors and Hodgkin's disease.

DrugBank: Lomustine

www.drugbank.ca/drugs/DB01206

Name, Lomustine. Accession Number, DB01206 (APRD00292). Type, Small Molecule. Groups, Approved. Description. An alkylating agent of value against both ...

More Info

Lomustine - Chemotherapy Drugs - Chemocare

chemocare.com

Drug type: Lomustine is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as an "alkylating agent." (For more detail ...

Lomustine - National Cancer Institute

www.cancer.gov

Feb 27, 2012 ... This page contains brief information about lomustine and a collection of links to more information about the use of this drug, research results, ...

CeeNU (Lomustine Capsules): Side Effects, Interactions, Warning ...

www.rxlist.com

WARNING. CeeNU (lomustine) should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic ...